Back to today’s briefing

Story perspectives

New CGM Study Predicts Diabetes Complications Better Than HbA1c

1/23/2025

44 10

Summary

Story summary

A groundbreaking study in Diabetes Technology & Therapeutics reveals that 14-day continuous glucose monitoring (CGM) can forecast microvascular complications in type 1 diabetes, rivaling traditional glycated hemoglobin tests. Researchers emphasize time-in-range (TIR) as a crucial indicator of glycemic control, directly connecting it to the risks of retinopathy and microalbuminuria.

1 of 1

Story summary

A groundbreaking study in Diabetes Technology & Therapeutics reveals that 14-day continuous glucose monitoring (CGM) can forecast microvascular complications in type 1 diabetes, rivaling traditional glycated hemoglobin tests. Researchers emphasize time-in-range (TIR) as a crucial indicator of glycemic control, directly connecting it to the risks of retinopathy and microalbuminuria.